Ani Pharmaceuticals ANIP
NASDAQ ANIP
$70.70 +0.47 (+0.67%)
As of: Sep 9, 2026 · 3:59 PM EDT

Ani Pharmaceuticals (ANIP) Interest Coverage Ratio Growth (1y) (2012 - 2013)

Analysis

Ani Pharmaceuticals (ANIP) Interest Coverage Ratio Growth (1y) (2012 - 2013) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover Growth (1y) (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn -
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn -97.39%
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn -85.68%
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn -
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn 95.71%
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn -649.91%
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn -
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn -11.17%
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn 12,688.80%
10 RedHill Biopharma 178.35 Mn 178.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 305,308.43%
Jun 30, 2013 -961.23%
Dec 31, 2012 70.46%
Sep 30, 2012 96.50%